"The tests that we have conducted comparing those people, who were vaccinated, with the population that has not been immunized yet, enabled us to prove that these were very effective," he added.
Concerning the work of the INS Biomedicine Laboratory, Mr. Sagasti indicated that it is providing an extraordinary and useful service because —on the one hand— it processes molecular tests and also does scientific and technical work in a very advanced way.
"The equipment, which has just been installed in this laboratory, is the third in South America and the fourth in the entire hemisphere; only Brazil, Argentina, and the United States have genomic sequencing equipment that allows 1,200 tests to be carried out instead of the 100 that used to be carried out previously," he explained.